Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S Post author: Post published:February 13, 2024 Post category:uncategorized The effectiveness of ritonavir-boosted nirmatrelvir (NMV-r) against Omicron variants. You Might Also Like Staying active reduces waist gain after you quit smoking July 1, 2025 From Cells to Drugs: How Cell Painting is Transforming Drug Discovery November 1, 2023 Marijuana use linked to elevated nicotine levels in plastic surgery patients August 29, 2024